Eris Lifesciences, HEG advance on Vanguard's purchases

Image
Capital Market
Last Updated : Mar 19 2018 | 10:50 AM IST

Shares of Eris Lifesciences and HEG gained by 1.45% and 6.38% respectively at 10:30 IST on BSE after Vanguard Group purchased bulk shares of these companies through open market transactions on Friday, 16 March 2018.

Eris Lifesciences (up 1.45% at Rs 824) and HEG (up 6.38% at Rs 3,345.25) advanced.

However, shares of Capital First were down 0.73% at Rs 643.50. Vanguard Group bought 9.31 lakh shares of Capital First at Rs 648.65 per share in a bulk deal on the NSE on Friday, 16 March 2018. Capital First is a financial institution focused on providing debt financing to micro small and medium enterprises (MSME) and Indian consumers.

Meanwhile, the S&P BSE Sensex was down 39.21 points or 0.12% at 33,136.79.

Vanguard Group purchased 10.12 lakh shares of Eris Lifesciences at Rs 814.88 per share in a bulk deal on the NSE on Friday, 16 March 2018. Eris Lifesciences is one of the fastest growing companies within the chronic and acute categories of the Indian Branded Formulations market such as: cardiovascular; anti-diabetes; vitamins; gastroenterology and gynaecology.

Vanguard Group bought 4.72 lakh shares of HEG at Rs 3,152.52 per share in a bulk deal on the NSE on Friday, 16 March 2018. HEG is the leading manufacturer and exporter of graphite electrodes in India.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 19 2018 | 10:31 AM IST

Next Story